Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


(Plasmid #80032)


Item Catalog # Description Quantity Price (USD)
Plasmid 80032 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone manufacturer
  • Backbone size (bp) 2892
  • Modifications to backbone
    a NotI-NotI fragment containing pAAV-MCS backbone was used for the cloning of pAAV-2Aneo.
  • Vector type
    AAV, Cre/Lox ; a platform vector to construct targeting vectors by inserting 5' and 3' arms
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Cloning Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Upon construction of a targeting vector with pAAV-2Aneo, the “frame adjuster” should be first cleaved with BspEI, MluI, or BsrGI and then self-religated so that 2Aneo is translated in frame with the 5’ portion of the targeted endogenous gene. This truncation of the frame adjuster should be done prior to the incorporation of 5' and 3' arms into pAAV-2Aneo, if arms carry restriction enzyme sites cleaved during the truncation of the frame adjuster (i.e., BspEI, MluI, or BsrGI sites). This plasmid and pAAV-2Aneo v2 differ only by the sequences of the frame adjusters.

A following article describes how to use pAAV-2Aneo to construct AAV-based targeting vectors: Karnan et al. Bio-Protoc, 6(24): e2058, 2016. (

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pAAV-2Aneo was a gift from Hiroyuki Konishi (Addgene plasmid # 80032 ; ; RRID:Addgene_80032)
  • For your References section:

    Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide. Karnan S, Ota A, Konishi Y, Wahiduzzaman M, Hosokawa Y, Konishi H. Nucleic Acids Res. 2015 Dec 10. pii: gkv1338. 10.1093/nar/gkv1338 PubMed 26657635